Athenex Pharma Solutions, LLC

Form 483 issued September 16, 2022 · Clarence, New York

Inspection
Sep 8 – Sep 16, 2022
Observations
1
Pages
3
FEI number
3008876196

In short: On September 16, 2022, FDA issued a Form 483 with 1 observation to Athenex Pharma Solutions, LLC in Clarence, New York (FEI 3008876196) after an inspection that ran Sep 8 – Sep 16, 2022. The investigators were Junho Pak and Syeda N. Mahazabin. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review the failure of a batch or any of its…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Athenex Pharma Solutions, LLC?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Athenex Pharma Solutions, LLC?

Junho Pak and Syeda N. Mahazabin are named on this Form 483, for the inspection of Sep 8 – Sep 16, 2022. Each investigator has a profile showing what they cite most.

When was Athenex Pharma Solutions, LLC inspected by FDA?

The inspection ran Sep 8 – Sep 16, 2022, and the Form 483 is dated September 16, 2022.

How do I get the full Form 483 for Athenex Pharma Solutions, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free